Schedule 13G ownership disclosure
Oramed Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 68403P203
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 409,316
- Percent of class
- 3.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001044321-15-000002
- Form type
- SC 13G
- Filer
- MARXE AUSTIN W & GREENHOUSE DAVID M
- CIK
- CIK 1044321
- Filed
- Jan 09, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership